Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease

被引:12
作者
Hutoran, M [1 ]
Britan, E [1 ]
Baraz, L [1 ]
Blumenzweig, I [1 ]
Steinitz, M [1 ]
Kotler, M [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91120 Jerusalem, Israel
基金
以色列科学基金会;
关键词
HIV-1; protease; Vif; synthetic peptides; APOBEC3G;
D O I
10.1016/j.virol.2004.09.029
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) auxiliary gene vif is essential for virus propagation in peripheral blood lymphocytes, macrophages, and in some T-cell lines. Previously, it was demonstrated that Vif inhibits the autoprocessing of truncated HIV-1 Gag Pol polyproteins expressed in bacterial cells, and that purified recombinant Vif and Vif-derived peptides inhibit and bind HIV-1 protease (PR). Here we show that Vif interacts with the N-tenninal region of HIV-1 PR, and demonstrate that peptide derived from the N-tenninal region of PR abrogates Vif function in non-permissive cells. Specifically, we show that (i) Vif protein binds HIV-1 PR, but not covalently linked tethered PR-PR; (ii) the four amino acids residing at the N terminus of HIV-1 PR are essential for Vif/PR interaction; (iii) synthetic peptide derived from the N ten-ninus of HIV-1 PR inhibits Vif/PR binding; and (iv) this peptide inhibits the propagation of HIV-1 in restrictive cells. Based on these data, we suggest that Vif interacts with the dimerization sites of the viral protease, and that peptide residing at the N terminus of PR abrogates Vif function(s). (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 57 条
[1]   Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice [J].
Aldrovandi, GM ;
Zack, JA .
JOURNAL OF VIROLOGY, 1996, 70 (03) :1505-1511
[2]   Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production [J].
Baraz, L ;
Friedler, A ;
Blumenzweig, I ;
Nussinuv, O ;
Chen, N ;
Steinitz, M ;
Gilon, C ;
Kotler, M .
FEBS LETTERS, 1998, 441 (03) :419-426
[3]   The Vif protein of human immunodeficiency virus type 1 (HIV-1): Enigmas and solutions [J].
Baraz, L ;
Kotler, M .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (02) :221-231
[4]   Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region [J].
Baraz, L ;
Hutoran, M ;
Blumenzweig, I ;
Katzenellenbogen, M ;
Friedler, A ;
Gilon, C ;
Steinitz, M ;
Kotler, M .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :2225-2230
[5]   Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors:: co-encapsidation and interference with viral protease-mediated Gag processing [J].
Bardy, M ;
Gay, B ;
Pébernard, S ;
Chazal, N ;
Courcoul, M ;
Vigne, R ;
Decroly, E ;
Boulanger, P .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :2719-2733
[6]   HIV-1 vif-derived peptide inhibits drug-resistant HIV proteases [J].
Blumenzweig, I ;
Baraz, L ;
Friedler, A ;
Danielson, UH ;
Gilon, C ;
Steinitz, M ;
Kotler, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (04) :832-840
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[8]   Phenotypically Vif(-) human immunodeficiency virus type 1 is produced by chronically infected restrictive cells [J].
Bouyac, M ;
Rey, F ;
Nascimbeni, M ;
Courcoul, M ;
Sire, J ;
Blanc, D ;
Clavel, F ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2473-2477
[9]   The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G [J].
Conticello, SG ;
Harris, RS ;
Neuberger, MS .
CURRENT BIOLOGY, 2003, 13 (22) :2009-2013
[10]  
CULLEN B, 1987, METHOD ENZYMOL, V152, P693